Internal Medicine, Botucatu Medical School-UNESP, Sao Paulo State University, Sao Paulo, Brazil.
Clin J Am Soc Nephrol. 2012 Jun;7(6):887-94. doi: 10.2215/CJN.11131111. Epub 2012 Mar 29.
Peritoneal dialysis is still used for AKI in developing countries despite concerns about its limitations. The objective of this study was to explore the role of high-volume peritoneal dialysis in AKI patients in relation to metabolic and fluid control, outcome, and risk factors associated with death.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A prospective study was performed on 204 AKI patients who were assigned to high-volume peritoneal dialysis (prescribed Kt/V=0.60/session) by flexible catheter and cycler; 150 patients (80.2%) were included in the final analysis.
Mean age was 63.8±15.8 years, 70% of patients were in the intensive care unit, and sepsis was the main etiology of AKI (54.7%). BUN and creatinine levels stabilized after four sessions at around 50 and 4 mg/dl, respectively. Fluid removal and nitrogen balance increased progressively and stabilized around 1200 ml and -1 g/d after four sessions, respectively. Weekly delivered Kt/V was 3.5±0.68. Regarding AKI outcome, 23% of patients presented renal function recovery, 6.6% of patients remained on dialysis after 30 days, and 57.3% of patients died. Age and sepsis were identified as risk factors for death. In urine output, increase of 1 g in nitrogen balance and increase of 500 ml in ultrafiltration after three sessions were identified as protective factors.
High-volume peritoneal dialysis is effective for a selected AKI patient group, allowing adequate metabolic and fluid control. Age, sepsis, and urine output as well as nitrogen balance and ultrafiltration after three high-volume peritoneal dialysis sessions were associated significantly with death.
尽管存在对其局限性的担忧,但腹膜透析在发展中国家仍被用于急性肾损伤。本研究旨在探讨高容量腹膜透析在急性肾损伤患者中的作用,以及与代谢和液体控制、预后以及与死亡相关的危险因素的关系。
设计、设置、参与者和测量:对 204 名急性肾损伤患者进行了前瞻性研究,这些患者通过软导管和循环机被分配接受高容量腹膜透析(处方 Kt/V=0.60/次);最终有 150 名患者(80.2%)纳入了最终分析。
平均年龄为 63.8±15.8 岁,70%的患者在重症监护病房,感染是急性肾损伤的主要病因(54.7%)。BUN 和肌酐水平在四个疗程后稳定在 50 和 4mg/dl 左右。液体清除和氮平衡逐渐增加,分别在四个疗程后稳定在 1200ml 和-1g/d 左右。每周的 Kt/V 为 3.5±0.68。关于急性肾损伤的结果,23%的患者肾功能恢复,6.6%的患者在 30 天后仍需透析,57.3%的患者死亡。年龄和感染被确定为死亡的危险因素。在尿量方面,三个疗程后氮平衡增加 1g 和超滤增加 500ml 被确定为保护因素。
高容量腹膜透析对选定的急性肾损伤患者群体有效,可实现充分的代谢和液体控制。年龄、感染以及三个高容量腹膜透析疗程后的尿量、氮平衡和超滤与死亡显著相关。